Adrian Hapca

Safer Prescribing — A Trial of Education, Informatics, and Financial Incentives

Tobias Dreischulte, Peter T. Donnan, Aileen Grant et al. · New England Journal of Medicine · 2016 · 196 citations · Full text

Medicine, Family Medicine, Pharmacotherapy +16

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

Michael Flower, Vilija Lomeikaite, Marc Ciosi et al. · Brain · 2019 · 169 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

Kees Okkersen, Cecilia Jimenez‐Moreno, Stephan Wenninger et al. · The Lancet Neurology · 2018 · 121 citations · Full text

Medicine, Rehabilitation Medicine, Physical Activity +11

Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial

Andrew Radley, Marijn de Bruin, Sarah K. Inglis et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 89 citations · Full text

Pharmacy, Pharmacotherapy, Pharmacy Practice +16

Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care

John Dillon, Michael H. Miller, Emma Robinson et al. · Journal of Hepatology · 2019 · 82 citations · Full text

Medicine, Biomedical Informatics, Health Informatics +16